Hamid Ghandehari, PhD, is a professor in the Department of Pharmaceutics, Pharmaceutical Chemistry, and Bioengineering at the University of Utah, and a member of the Imaging, Diagnostics, and Therapeutics Program. Ghandehari is also a faculty member with the Utah Science Technology and Research Initiative (USTAR) at the University of Utah.

Ghandehari studies new ways to deliver targeted cancer therapies. He researches the design of polymers for targeted delivery of drugs to tumors. He is the co-founder and co-director of the Nano Institute of Utah. A major focus of the Nano Institute is collaboration on the University of Utah campus and beyond to advance the growing field of cancer nanotechnology.

Ghandehari earned both a bachelor’s degree and PhD from the University of Utah.